Document Detail


A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension.
MedLine Citation:
PMID:  8739678     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The intraocular pressure reducing effect and side-effects of latanoprost, a phenyl-substituted prostaglandin analogue, were compared with those of timolol, in a group of 31 glaucomatous or ocular hypertensive patients, divided into three subgroups. The study was randomized and double masked. At the end of 6 month's treatment with latanoprost 0.005% once daily, either as a morning dose or as an evening dose, there was a reduction in intraocular pressure of 33% (p < 0.001) and 36% (p < 0.001), respectively. The intraocular pressure reduction of timolol 0.5%, administered twice daily was 26% (p < 0.001). There was no significant difference in conjunctival hyperemia between the groups and there were few subjective symptoms in any of the patients. One patient with a light green-brown iris, treated with latanoprost in one eye only, exhibited an increase in iris colour in the treated eye at week 26, and did not show any signs of reversion 9 months after discontinuing the therapy. It may be concluded that latanoprost is well tolerated and at least as effective as timolol in reducing intraocular pressure in patients with glaucoma or ocular hypertension when applied once daily. The exact mechanism behind the increase in iris pigmentation and the clinical significance of this previously unknown side-effect needs to be investigated further.
Authors:
B Friström
Related Documents :
6489468 - Exogenous na-hyaluronate in the anterior chamber of the owl monkey and its effect on th...
15666068 - Effect of unilateral forced nostril breathing on tonic accommodation and intraocular pr...
18202708 - The effects of dorzolamide 2% and dorzolamide/timolol fixed combination on retinal and ...
2334628 - Effects of nebulized lignocaine on the intraocular pressure responses to tracheal intub...
15255788 - Effects of low-dose dopamine on ventilation in patients with chronic obstructive pulmon...
1232098 - Intracranial pressure in adult non-tumoral hydrocephalus.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta ophthalmologica Scandinavica     Volume:  74     ISSN:  1395-3907     ISO Abbreviation:  Acta Ophthalmol Scand     Publication Date:  1996 Apr 
Date Detail:
Created Date:  1996-10-04     Completed Date:  1996-10-04     Revised Date:  2008-03-17    
Medline Journal Info:
Nlm Unique ID:  9507578     Medline TA:  Acta Ophthalmol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  140-4     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, University of Linköping, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / administration & dosage,  adverse effects,  therapeutic use*
Adult
Aged
Aged, 80 and over
Double-Blind Method
Female
Follow-Up Studies
Glaucoma, Open-Angle / drug therapy*,  physiopathology
Humans
Intraocular Pressure / drug effects
Male
Middle Aged
Ocular Hypertension / drug therapy*,  physiopathology
Ophthalmic Solutions
Prostaglandins F, Synthetic / administration & dosage,  adverse effects,  therapeutic use*
Safety
Scandinavia
Timolol / administration & dosage,  adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Ophthalmic Solutions; 0/Prostaglandins F, Synthetic; 130209-82-4/latanoprost; 26839-75-8/Timolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Scanning Laser Ophthalmoscope microperimetry compared with Octopus perimetry in normal subjects.
Next Document:  Prognostic factors in long-term intraocular pressure control following combined phacoemulsification ...